Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-03-07

Clinical Trial Update: Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Bladder Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a Beta-3 agonist for psychological distress and bladder blood flow in women with overactive bladder; the study has been withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Overactive Bladder Syndrome | Phase 4 | Status: WITHDRAWN